Tuberculosis in children exposed at home to multidrug-resistant tuberculosis

Pediatric Infectious Disease Journal

Volumn 32, Issue 2, 2013, Pages 115-119

  Becerra, Mercedes C ^a,b,c   Franke, Molly F ^a,b   Appleton, Sasha C ^a,b   Joseph, J Keith ^a,b,c   Bayona, Jaime ^a,b   Atwood, Sidney S ^c   Mitnick, Carole D ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Brigham and Women's Hospital ^*

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

contact investigation; disease burden; drug resistance; evaluation; follow up; household; incidence; multidrug resistant tuberculosis; pediatric; person years; prevalence

Indexed keywords

ISONIAZID; RIFAMPICIN;

ARTICLE; CHILD; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HOME; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; PERU; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENVIRONMENTAL EXPOSURE; FAMILY CHARACTERISTICS; FEMALE; GENOTYPE; HUMANS; INCIDENCE; INFANT; MALE; MYCOBACTERIUM TUBERCULOSIS; PERU; PREVALENCE; RETROSPECTIVE STUDIES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84873055199     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31826f6063     Document Type: Article

References (36)

1. Brent AJ, Anderson ST, Kampmann B. Childhood tuberculosis: out of sight, out of mind? Trans R Soc Trop Med Hyg. 2008;102:217-218.
2. Keshavjee S, Farmer PE. Picking up the pace-scale-up of MDR tuberculosis treatment programs. N Engl J Med. 2010;363:1781-1784.
3. Becerra MC, Appleton SC, Franke MF, et al. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study. Lancet. 2011;377:147-152.
4. Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multi-drug-resistant tuberculosis in Lima, Peru. N Engl J Med. 2003;348: 119-128.
5. Mitnick CD, Shin SS, Seung KJ, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008;359:563-574.
6. Ministerio de Salud del Perú. Actualización de la doctrina, normas y proced-imientos para el control de la tuberculosis en el Perú. Lima, Peru: Ministerio de Salud del Perú; 1995.
7. Stegen G, Jones K, Kaplan P. Criteria for guidance in the diagnosis of tuberculosis. Pediatrics. 1969;43:260-263.
8. Cohen T, Murray M, Abubakar I, et al. Multiple introductions of multi drug-resistant tuberculosis into households, Lima, Peru. Emerging Infect Dis. 2011;17:969-975.
9. World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. WHO/CDS/TB/2000.278. Geneva, Switzerland: World Health Organization; 2000.
10. Wolter KM. Introduction to Variance Estimation. 2nd ED. New York, NY: Springer-Verlag Inc.; 2007.
11. Lilienfeld DE, Stolley PD. Foundations of Epidemiology. 3rd ED. New York, NY: Oxford University Press; 1994.
12. Fay M P, Feuer EJ. Confdence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med. 1997;16:791-801.
13. Rieder HL. Contacts of tuberculosis patients in high-incidence countries. Int J Tuberc Lung Dis. 2003;7(12 suppl 3):S333-S336.
14. Marais BJ, Gie R P, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemother-apy era. Int J Tuberc Lung Dis. 2004;8:392-402.
15. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis. 2004;8:636-647.
16. Schaaf HS, Vermeulen HA, Gie R P, et al. Evaluation of young children in household contact with adult multidrug-resistant pulmonary tuberculosis cases. Pediatr Infect Dis J. 1999;18:494-500.
17. Schaaf HS, Gie R P, Kennedy M, et al. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up. Pediatrics. 2002;109:765-771.
18. Marais BJ, Gie R P, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004;8:392-402.
19. Schaaf HS, Van Rie A, Gie R P, et al. Transmission of multidrug-resistant tuberculosis. Pediatr Infect Dis J. 2000;19:695-699.
20. Mukherjee JS, Joseph JK, Rich ML, et al. Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru. Int J Tuberc Lung Dis. 2003;7:637-644.
21. Drobac PC, Mukherjee JS, Joseph JK, et al. Community-based therapy for children with multidrug-resistant tuberculosis. Pediatrics. 2006; 117:2022-2029.
22. Newton SM, Brent AJ, Anderson S, et al. Paediatric tuberculosis. Lancet Infect Dis. 2008;8:498-510.
23. Swaminathan S, Rekha B. Pediatric tuberculosis: global overview and challenges. Clin Infect Dis. 2010;50(suppl 3):S184-S194.
24. Starke Jr. New concepts in childhood tuberculosis. Curr Opin Pediatr. 2007;19:306-313.
25. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. UNAIDS/WHO Epidemiological Fact Sheet: Peru-2004 Update. Available at: http://data.unaids.org/publications/Fact-Sheets01/peru-en.pdf. Accessed June 20, 2011.
26. World Health Organization. Global tuberculosis control: epidemiology, strategy, fnancing. Geneva, Switzerland: World Health Organization; 2009.
27. Thomas TA, Shenoi S V, Heysell SK, et al. Extensively drug-resistant tuberculosis in children with human immunodefciency virus in rural South Africa. Int J Tuberc Lung Dis. 2010;14:1244-1251.
28. Keshavjee S, Gelmanova IY, Pasechnikov AD, et al. Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease. Ann N Y Acad Sci. 2008;1136: 1-11.
29. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. WHO/HTM/TB/2006.371. Geneva, Switzerland: World Health Organization; 2006.
30. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis-Emergency Update 2008. WHO/HTM/TB/2008.402. Geneva, Switzerland: World Health Organization; 2008.
31. Cain K P, Nelson LJ, Cegielski J P. Global policies and practices for managing persons exposed to multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2010;14:269-274.
32. Fraser A, Paul M, Attamna A, et al. Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis. Cochrane Database Syst Rev. 2006;2:CD005435.
33. Sneag DB, Schaaf HS, Cotton MF, et al. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases. Pediatr Infect Dis J. 2007;26:1142-1146.
34. Feja K, McNelley E, Tran CS, et al. Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003. Pediatr Infect Dis J. 2008;27:907-912.
35. Donald PR, Maher D, Qazi S. A research agenda to promote the management of childhood tuberculosis within national tuberculosis programmes. Int J Tuberc Lung Dis. 2007;11:370-380.
36. Cobelens FG, Heldal E, Kimerling ME, et al.; Working Group on MDR-TB of the Stop TB Partnership. Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda. PLoS Med. 2008;5:e150.